$109 Million is the total value of Omega Fund Management, LLC's 12 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| REPL | Replimune Group | $51,352,568 | -26.3% | 3,001,319 | 0.0% | 47.17% | +20.8% | |
| NUVB | Nuvation Bio | $20,196,936 | -25.6% | 15,072,340 | 0.0% | 18.55% | +22.0% | |
| IKNA | Ikena Oncology | $9,738,703 | -34.0% | 2,249,123 | 0.0% | 8.94% | +8.2% | |
| MORF | Morphic Holding | $7,098,572 | -60.0% | 309,846 | 0.0% | 6.52% | -34.5% | |
| KRON | Kronos Bio | $4,963,768 | -24.4% | 3,818,283 | 0.0% | 4.56% | +23.9% | |
| SPRB | Spruce Biosciences | $4,883,910 | +5.1% | 2,161,022 | 0.0% | 4.49% | +72.3% | |
| SANA | Sana Biotechnology, Inc. | $3,265,313 | -35.1% | 843,750 | 0.0% | 3.00% | +6.5% | |
| IMUX | Immunic Inc | $2,628,595 | -41.4% | 1,788,160 | 0.0% | 2.41% | -4.0% | |
| Theseus Pharmaceuticals | $1,913,879 | -71.2% | 711,479 | 0.0% | 1.76% | -52.7% | ||
| ALPN | Sell | Alpine Immune Sciences | $1,759,865 | -91.6% | 153,700 | -92.4% | 1.62% | -86.2% |
| Syros Pharmaceuticals | $992,517 | +25.4% | 251,270 | 0.0% | 0.91% | +105.9% | ||
| Senti Biosciences, Inc. | $80,862 | -34.1% | 195,792 | 0.0% | 0.07% | +7.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Paratek Pharmaceuticals, Inc. | 34 | Q1 2023 | 39.1% |
| FibroGen, Inc. | 28 | Q3 2021 | 14.3% |
| Jounce Therapeutics | 25 | Q1 2023 | 11.6% |
| Pieris Pharmaceuticals | 23 | Q1 2021 | 5.2% |
| Replimune Group | 21 | Q3 2023 | 47.2% |
| Cidara Therapeutics | 20 | Q3 2021 | 5.8% |
| Morphic Holding | 18 | Q3 2023 | 22.0% |
| Immunic Inc | 18 | Q3 2023 | 9.0% |
| Dicerna Pharmaceuticals | 18 | Q1 2019 | 3.7% |
| Egalet | 17 | Q4 2018 | 19.6% |
View Omega Fund Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| 13F-HR/A | 2021-11-15 |
View Omega Fund Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.